المؤلفون: McGraw KL; Department of Malignant Hematology and., Cheng CH; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL., Chen YA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL., Hou HA; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Nilsson B; Department of Laboratory Medicine, Section of Hematology and Transfusion Medicine, Lund University, Lund, Sweden., Genovese G; Stanley Center for Psychiatric Research and.; Program in Medical and Population Genetics, Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA.; Department of Genetics, Harvard Medical School, Boston, MA., Cluzeau T; Cote d'Azur University, Centre Hospitalier Universitaire of Nice, Nice, France., Pellagatti A; Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and Oxford Biomedical Research Centre Haematology Theme, Oxford, United Kingdom., Przychodzen BP; Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH., Mallo M; Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Catala d'Oncologia-Hospital GermansTrias i Pujol, Universitat Autonòma de Barcelona, Badalona, Barcelona, Spain., Arenillas L; Laboratori de Citologia Hematòlogica, Servei de Patologia, Hospital del Mar, Barcelona, Spain., Mohamedali A; Department of Haematological Medicine, Kings College London, London, United Kingdom., Adès L; Senior Hematology Department, Hopital Saint Louis, Paris, France., Sallman DA; Department of Malignant Hematology and., Padron E; Department of Malignant Hematology and., Sokol L; Department of Malignant Hematology and., Moreilhon C; Cote d'Azur University, Centre Hospitalier Universitaire of Nice, Nice, France., Raynaud S; Cote d'Azur University, Centre Hospitalier Universitaire of Nice, Nice, France., Tien HF; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Boultwood J; Bloodwise Molecular Haematology Unit, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford and Oxford Biomedical Research Centre Haematology Theme, Oxford, United Kingdom., Ebert BL; Departments of Medicine and Medical Oncology, Harvard Medical School and Brigham and Women's Hospital, Boston, MA; and., Sole F; Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Catala d'Oncologia-Hospital GermansTrias i Pujol, Universitat Autonòma de Barcelona, Badalona, Barcelona, Spain., Fenaux P; Senior Hematology Department, Hopital Saint Louis, Paris, France., Mufti GJ; Department of Haematological Medicine, Kings College London, London, United Kingdom., Maciejewski JP; Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH., Kanetsky PA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL., List AF; Department of Malignant Hematology and.

المصدر: Blood advances [Blood Adv] 2019 Nov 26; Vol. 3 (22), pp. 3579-3589.

نوع المنشور: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Genome-Wide Association Study* , Polymorphism, Single Nucleotide* , Quantitative Trait Loci*, Myelodysplastic Syndromes/*genetics, Chromosome Deletion ; Chromosomes, Human, Pair 5 ; Gene Expression Regulation ; Genomics/methods ; Humans ; Myelodysplastic Syndromes/diagnosis

المؤلفون: Reid BM; Moffitt Cancer Center & Research Institute, Tampa, Florida., Permuth JB; Moffitt Cancer Center & Research Institute, Tampa, Florida., Chen YA; Moffitt Cancer Center & Research Institute, Tampa, Florida., Teer JK; Moffitt Cancer Center & Research Institute, Tampa, Florida., Monteiro AN; Moffitt Cancer Center & Research Institute, Tampa, Florida., Chen Z; Moffitt Cancer Center & Research Institute, Tampa, Florida., Tyrer J; University of Cambridge, Cambridge, United Kingdom., Berchuck A, Chenevix-Trench G, Doherty JA; The Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire., Goode EL; Mayo Clinic, Rochester, Minnesota., Iverson ES; Duke University, Durham, North Carolina., Lawrenson K; Cedars-Sinai Hospital, Los Angeles, California., Pearce CL; School of Public Health, University of Michigan, Ann Arbor, Michigan., Pharoah PD; University of Cambridge, Cambridge, United Kingdom., Phelan CM; Moffitt Cancer Center & Research Institute, Tampa, Florida., Ramus SJ; Keck School of Medicine, University of Southern California, Los Angeles, California., Rossing MA; Fred Hutchinson Cancer Research Center, Seattle, Washington., Schildkraut JM; University of Virginia, Charlottesville, Virginia., Cheng JQ; Moffitt Cancer Center & Research Institute, Tampa, Florida., Gayther SA; Cedars-Sinai Hospital, Los Angeles, California., Sellers TA

مؤلفون مشاركون: Ovarian Cancer Association Consortium, Australian Ovarian Cancer Study Group and the Ovarian Cancer Association Consortium, Ovarian Cancer Association Consortium

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2017 Jan; Vol. 26 (1), pp. 116-125. Date of Electronic Publication: 2016 Dec 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease/*epidemiology , Neoplasms, Glandular and Epithelial/*genetics , Ovarian Neoplasms/*genetics , Polymorphism, Single Nucleotide/*genetics , RNA, Long Noncoding/*genetics, Adult ; Aged ; Carcinoma, Ovarian Epithelial ; Case-Control Studies ; Female ; Genetic Loci ; Genome-Wide Association Study ; Genotype ; Humans ; Middle Aged ; Neoplasms, Glandular and Epithelial/epidemiology ; Neoplasms, Glandular and Epithelial/pathology ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/pathology ; Prevalence ; Risk Assessment

المؤلفون: Amankwah EK; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America.; Clinical and Translational Research Organization, All Children's Hospital Johns Hopkins Medicine, St. Petersburg, Florida, United States of America., Lin HY; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Tyrer JP; Centre for Cancer Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom., Lawrenson K; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Dennis J; Centre for Cancer Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom., Chornokur G; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America., Aben KK; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Comprehensive Cancer Center The Netherlands, Nijmegen, The Netherlands., Anton-Culver H; Genetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research and Prevention, Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, California, United States of America., Antonenkova N; Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N, Minsk, Belarus., Bruinsma F; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia., Bandera EV; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States of America., Bean YT; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America., Beckmann MW; Erlangen-Nuremberg Comprehensive Cancer Center, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen EMN, Germany., Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, United States of America., Bjorge L; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Bogdanova N; Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany., Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America., Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada., Bunker CH; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America., Butzow R; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, HUS, Finland.; Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland., Campbell IG; Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia.; Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Carty K; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom.; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Chen Z; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Chen YA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, United States of America., Cramer DW; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America., Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Dansonka-Mieszkowska A; Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., du Bois A; Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; Department of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany., Despierre E; Division of Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Dicks E; Centre for Cancer Epidemiology, Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom., Doherty JA; Department of Community and Family Medicine, Section of Biostatistics & Epidemiology, Dartmouth Medical School, Hanover, New Hampshire, United States of America.; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washigton, United States of America., Dörk T; Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany., Dürst M; Department of Gynecology, Friedrich Schiller University, Jena, Germany., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Eccles DM; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom., Edwards RP; Ovarian Cancer Center of Excellence, Department of Obstetrics Gynecology/RS, Division of Gynecological Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America., Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany., Fasching PA; Erlangen-Nuremberg Comprehensive Cancer Center, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen EMN, Germany.; Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America., Fridley BL; Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas, United States of America., Gao YT; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China., Gentry-Maharaj A; Women's Cancer, UCL EGA Institute for Women's Health, London, United Kingdom., Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia., Glasspool R; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Goodman MT; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America., Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Harrington P; Centre for Cancer Epidemiology, Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom., Harter P; Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; Department of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany., Hasmad HN; Cancer Research Initiatives Foundation, Sime Darby Medical Center, Subang Jaya, Malaysia., Hein A; Erlangen-Nuremberg Comprehensive Cancer Center, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen EMN, Germany., Heitz F; Department of Gynaecology and Gynaecologic Oncology, Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.; Department of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany., Hildebrandt MA; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Hillemanns P; Radiation Oncology Research Unit, Hannover Medical School, Hannover, Germany., Hogdall CK; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hogdall E; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark., Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., Iversen ES; Department of Statistics, Duke University, Durham, North Carolina, United States of America., Jakubowska A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Ji BT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive, Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America., Jim H; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Forida, United States of America., Kellar M; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America., Kiemeney LA; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Krakstad C; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Kjaer SK; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Kupryjanczyk J; Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Lambrechts D; Vesalius Research Center, VIB, University of Leuven, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium., Lambrechts S; Division of Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Le ND; Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada., Lee AW; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Lele S; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, United States of America., Leminen A; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, HUS, Finland., Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive, Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America., Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, United States of America., Liang D; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, United States of America., Lim BK; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia., Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Lu K; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Lundvall L; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Massuger LF; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Matsuo K; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., McGuire V; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America., McLaughlin JR; Public Health Ontario, Toronto, Ontario, Canada., McNeish I; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Menon U; Women's Cancer, UCL EGA Institute for Women's Health, London, United Kingdom., Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia., Modugno F; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America.; Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America.; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, United States of America., Ness RB; School of Public Health, The University of Texas, Houston, Texas, United States of America., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, HUS, Finland., Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Odunsi K; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, United States of America., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, United States of America., Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, United States of America., Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive, Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America., Weber RP; Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America., Paul J; CRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Pearce CL; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.; Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, United States of America., Pejovic T; Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, United States of America.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, United States of America., Pelttari LM; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, HUS, Finland., Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America., Pike MC; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, United States of America., Poole EM; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America., Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, United States of America., Rosen B; Department of Gynecology-Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada.; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Rossing MA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washigton, United States of America., Rothstein JH; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America., Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Runnebaum IB; Department of Gynecology, Friedrich Schiller University, Jena, Germany., Rzepecka IK; Department of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Salvesen HB; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Schernhammer E; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America., Schwaab I; Institut für Humangenetik, Wiesbaden, Germany., Shu XO; Epidemiology Center and Vanderbilt, Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennesse, United States of America., Shvetsov YB; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, United States of America., Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary, Glasgow, United Kingdom., Sieh W; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America., Song H; Centre for Cancer Epidemiology, Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom., Southey MC; Department of Pathology, University of Melbourne, Parkville, Victoria, Australia., Spiewankiewicz B; Department of Gynecologic Oncology, Institute of Oncology, Warsaw, Poland., Sucheston-Campbell L; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, United States of America., Teo SH; Cancer Research Initiatives Foundation, Sime Darby Medical Center, Subang Jaya, Malaysia.; University Malaya Medical Centre, University of Malaya, Kuala Lumpur, Maylaysia., Terry KL; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America., Thompson PJ; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America., Thomsen L; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Tangen IL; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Medicine, University of Bergen, Bergen, Norway., Tworoger SS; Obstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America., van Altena AM; Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Vierkant RA; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America., Vergote I; Division of Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium., Walsh CS; Women's Cancer Program at the Samuel Oschin Comprehensive, Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America., Wang-Gohrke S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America., Whittemore AS; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, California, United States of America., Wicklund KG; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washigton, United States of America., Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, United States of America., Wu AH; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Wu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Woo YL; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia., Yang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America., Zheng W; Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennesse, United States of America., Ziogas A; Genetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research and Prevention, Department of Epidemiology, School of Medicine, University of California Irvine, Irvine, California, United States of America., Kelemen LE; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, United States of America., Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, United States of America., Schildkraut JM; Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina, United States of America., Ramus SJ; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, United States of America., Monteiro AN; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida, United States of America., Gayther SA; Norris Comprehensive Cancer Center, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Narod SA; Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada., Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America., Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, United States of America.

مؤلفون مشاركون: Georgia Chenevix-Trench on behalf of the AOCS management group

المصدر: Genetic epidemiology [Genet Epidemiol] 2015 Dec; Vol. 39 (8), pp. 689-97. Date of Electronic Publication: 2015 Sep 24.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8411723 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2272 (Electronic) Linking ISSN: 07410395 NLM ISO Abbreviation: Genet Epidemiol Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease*, Epithelial-Mesenchymal Transition/*genetics , Neoplasms, Glandular and Epithelial/*epidemiology , Neoplasms, Glandular and Epithelial/*genetics , Ovarian Neoplasms/*epidemiology , Ovarian Neoplasms/*genetics , Polymorphism, Single Nucleotide/*genetics, Adult ; Aged ; Carcinoma, Ovarian Epithelial ; Female ; Genome-Wide Association Study ; Genotype ; Humans ; Middle Aged ; Odds Ratio ; Risk ; White People

المؤلفون: Lin HY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. ronnie.sebro@radiology.ucsf.edu, Chen YA, Tsai YY, Qu X, Tseng TS, Park JY

المصدر: Annals of human genetics [Ann Hum Genet] 2012 Jan; Vol. 76 (1), pp. 53-62. Date of Electronic Publication: 2011 Dec 11.

نوع المنشور: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0416661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-1809 (Electronic) Linking ISSN: 00034800 NLM ISO Abbreviation: Ann Hum Genet Subsets: MEDLINE

مواضيع طبية MeSH: Artificial Intelligence* , Models, Genetic* , Polymorphism, Single Nucleotide*, Decision Trees ; Genotype ; Humans ; Male ; Models, Statistical ; Prostatic Neoplasms/pathology ; Receptors, Estrogen/genetics

المؤلفون: Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida 33612-9416, USA., Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Sutphen R, McLaughlin J, Narod SA, Goode EL, Schildkraut JM, Fenstermacher D, Phelan CM, Sellers TA

المصدر: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2011 Jun; Vol. 20 (6), pp. 1131-45. Date of Electronic Publication: 2011 Mar 29.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE

مواضيع طبية MeSH: DNA, Mitochondrial/*genetics , Genes, Mitochondrial/*genetics , Ovarian Neoplasms/*genetics , Polymorphism, Single Nucleotide/*genetics, Adenocarcinoma, Clear Cell/genetics ; Adenocarcinoma, Mucinous/genetics ; Basic-Leucine Zipper Transcription Factors/genetics ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics ; Case-Control Studies ; Cystadenocarcinoma, Serous/genetics ; Endometrial Neoplasms/genetics ; Female ; Genotype ; Heat-Shock Proteins/genetics ; Humans ; Middle Aged ; Mitochondrial Proteins/genetics ; NF-E2-Related Factor 2/genetics ; Nuclear Respiratory Factor 1/genetics ; Oxidative Stress ; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ; Receptors, Estrogen/genetics ; Risk Factors ; Transcription Factors/genetics ; ERRalpha Estrogen-Related Receptor

المؤلفون: Lin, Hui-Yi, Chen, Y. Ann, Tsai, Ya-Yu, Qu, Xiaotao, Tseng, Tung-Sung, Park, Jong Y.

مصطلحات موضوعية: Male, Models, Statistical, Genotype, Models, Genetic, Receptors, Estrogen, Artificial Intelligence, Decision Trees, Humans, Prostatic Neoplasms, Polymorphism, Single Nucleotide, Article

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::ea6179b0a08a2e98bb11ad0db851d302
https://europepmc.org/articles/PMC3243917/